Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Manipal Health to...

    Manipal Health to acquire Fortis for Rs 6,500 crore: Report

    Written by Ruby Khatun Khatun Published On 2018-03-03T16:42:02+05:30  |  Updated On 3 March 2018 4:42 PM IST
    Manipal Health to acquire Fortis for Rs 6,500 crore: Report

    New Delhi: Manipal Health Enterprises (MHE), backed by TPG is close to acquiring Fortis Healthcare Ltd. and the deal is projected to be in the range of Rs 6,500 crore, according to a recent report published in DNA. The daily also adds that the deal is expected to be official early next week with an announcement


    Sources told DNA that Manipal will manage the hospital chain whereas TPG will invest in acquiring the network. TPG has been looking at the prospects on merging the two hospital chains i.e. Fortis Healthcare and Manipal Health Enterprises to create India's largest medical services group and also to come at equal with its rival, Apollo Hospitals which has over 10,000 beds.


    Fortis, when contacted by DNA said, "As a policy, we do not comment on market speculations. As shared earlier, the company is exploring options for fund raising."


    Fortis Healthcare on Thursday had reported a consolidated net loss of Rs 19.10 crore for the quarter ended December 2017 against a profit of Rs 453.29 crore in the year-ago period.


    Read also: DISMAL report: Fortis reports net loss for Sept, Dec quarters

    The company also reported its September quarter net loss at Rs 23.61 crore after it had sought a 15-day extension to declare earnings for the second and third quarter of the current financial year citing statutory auditors' inability to complete the audit before the stipulated Board meeting.


    Read also: Fortis Healthcare seeks 15-day extension to declare Q2, Q3 results


    Although the company presented its earnings report, the auditor to Fortis Healthcare, Deloitte Haskins & Sells LLP, said it had not performed an audit.


    It said the interim results have been reviewed by other auditors whose report has been furnished to them by the management.


    "Because of the significance of the matters... relating to the ongoing investigations... we were not able to obtain sufficient appropriate evidence to form a conclusion on the statement," it added.


    Fortis Healthcare has also said it will hire an external legal firm to carry out an investigation into alleged siphoning of cash by the firm’s promoters, Malvinder Singh and Shivinder Singh.


    Read also: Fortis to hire external legal firm to probe promoters fund misappropriation


    The duo, who last month resigned from the board of the company, is alleged to have taken Rs 473 crore out of the hospital company they control without board approval. The alleged financial impropriety happened about a year ago.


    Read also: Singh brothers resign from Fortis Healthcare board

    In its second and third quarter earnings statement, Fortis said its Audit and Risk Management Committee "decided to carry out an independent investigation through an external legal firm". "The scope of the investigation, inter alia, covers (a) inter-corporate deposits (ICDs) given by a wholly owned subsidiary of the company; (b) intra-group and related party transactions, including compliance with applicable laws and regulations," it said.


    Read also: Singh brothers took 78 million dollars out of Fortis: Report
    acquireFortisIHHManipal HealthManipal Health Enterprises Pvt LtdTPGVPS Healthcare
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok